`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_________________
`COMPLEX INNOVATIONS, LLC,
`Petitioner,
`v.
`
`Patent Owner
`
`ASTRAZENECA AB,
`_________________
`
`U.S. Patent U.S. Patent 7,759,328
`_________________
`
`DECLARATION OF SHARAD K. BIJANKI
`
`Complex Ex. 1016
`
`1
`
`
`
`1.
`
`I, Sharad K. Bijanki, a resident of Dekalb County, Georgia, hereby declare
`
`as follows:
`
`2.
`
`On information and belief, Exhibits 1001-1016 are true and accurate copies
`
`of the original documents, as shown in the table below:
`
`Exhibit No.
`
`Document Description
`
`Ex. 1001
`Ex. 1002
`Ex. 1003
`Ex. 1004
`
`Ex. 1005
`Ex. 1006
`
`Ex. 1007
`Ex. 1008
`Ex. 1009
`
`Ex. 1010
`Ex. 1011
`Ex. 1012
`Ex. 1013
`
`Ex. 1014
`
`Ex. 1015
`
`Ex. 1016
`
`U.S. Patent No. 7,759,328 (“’328 Patent”)
`The file history of the ’328 Patent
`U.S. Patent No. 6,123,924 (“Mistry”)
`World Intellectual Property Organization, Intl.
`Publication No. WO 02/03958 (“Rogueda”)
`U.S. Pat. No. 5,674,860 (“Carling”)
`World Intellectual Property Organization, International
`Publication No. WO 99/64014 (“Ekström”)
`U.S. Pat. App. Publ. No. 2003/0018019 (“Meade”)
`U.S. Pat. No. 8,142,763 (“Lewis”)
`News Articles about Loughborough AstraZeneca
`Research and Development
`Company History Website of Formulaction
`Curriculum Vitae of Martin Beasley, Ph.D.
`Declaration of Martin Beasley, Ph.D.
`Image File Wrapper of Carling, U.S. Appl. No.
`08/317,407, “Petition Decision,” (Mailroom date Jan. 9,
`2014)
`Law 360 Article by Millauer & White, The § 102(b)
`Foreign Filing Catch (2009)
`PATHOLOGIC BASIS OF DISEASE (Robbins, 5th Ed.
`1994).
`Declaration of Sharad K. Bijanki, Patent Attorney
`
`3.
`
`Patent Attorneys Todd Buck and Gregory Lowen, who are listed as
`
`attorneys-of-record of the law firm MORGAN LEWIS & BOCKIUS
`
`2
`
`2
`
`
`
`LLP, named under the corresponding address for U.S. Patent No.
`
`7,759,328, have agreed to accept service of process for all filings related
`
`to this inter partes review at the following e-mail addresses:
`
`patents@morganlewis.com
`
`todd.buck@morganlewis.com
`
`gregory.lowen@morganlewis.com
`
`4.
`
`I hereby declare under penalty of perjury under the laws of the United
`
`States of America that the foregoing is true and correct, and that all
`
`statements made of my own knowledge are true and that all statements
`
`made on information and belief are believed to be true. I understand that
`
`willful false statements and the like are punishable by fine or
`
`imprisonment, or both (18 U.S.C. § 1001).
`
`Executed on January 9, 2017.
`
`Sharad K. Bijanki
`Reg. No. 73,400
`
`3
`
`3